BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

305 related articles for article (PubMed ID: 25418873)

  • 1. Human papillomavirus prevalence in paired urine and cervical samples in women invited for cervical cancer screening.
    Burroni E; Bonanni P; Sani C; Lastrucci V; Carozzi F; ; Iossa A; Andersson KL; Brandigi L; Di Pierro C; Confortini M; Levi M; Boccalini S; Indiani L; Sala A; Tanini T; Bechini A; Azzari C
    J Med Virol; 2015 Mar; 87(3):508-15. PubMed ID: 25418873
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interest of human papillomavirus DNA quantification and genotyping in paired cervical and urine samples to detect cervical lesions.
    Ducancelle A; Legrand MC; Pivert A; Veillon P; Le Guillou-Guillemette H; De Brux MA; Beby-Defaux A; Agius G; Hantz S; Alain S; Catala L; Descamps P; Postec E; Caly H; Charles-Pétillon F; Labrousse F; Lunel F; Payan C
    Arch Gynecol Obstet; 2014 Aug; 290(2):299-308. PubMed ID: 24622934
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of urine and cervical samples for detecting human papillomavirus (HPV) with the Cobas 4800 HPV test.
    Bernal S; Palomares JC; Artura A; Parra M; Cabezas JL; Robles A; Martín Mazuelos E
    J Clin Virol; 2014 Dec; 61(4):548-52. PubMed ID: 25453566
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Detection of human papillomavirus in urine and cervical swabs from patients with invasive cervical cancer.
    Stanczuk GA; Kay P; Allan B; Chirara M; Tswana SA; Bergstrom S; Sibanda EN; Williamson AL
    J Med Virol; 2003 Sep; 71(1):110-4. PubMed ID: 12858416
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cervical cancer screening by cytology and human papillomavirus testing during pregnancy in French women with poor adhesion to regular cervical screening.
    Brun-Micaleff E; Coffy A; Rey V; Didelot MN; Combecal J; Doutre S; Daurès JP; Segondy M; Boulle N
    J Med Virol; 2014 Mar; 86(3):536-45. PubMed ID: 24114972
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High performance of a new PCR-based urine assay for HPV-DNA detection and genotyping.
    Tanzi E; Bianchi S; Fasolo MM; Frati ER; Mazza F; Martinelli M; Colzani D; Beretta R; Zappa A; Orlando G
    J Med Virol; 2013 Jan; 85(1):91-8. PubMed ID: 23097252
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of initial stream urine samples and cervical samples for detection of human papillomavirus.
    Hagihara M; Yamagishi Y; Izumi K; Miyazaki N; Suzuki T; Kato H; Nishiyama N; Koizumi Y; Suematsu H; Mikamo H
    J Infect Chemother; 2016 Aug; 22(8):559-62. PubMed ID: 27342077
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of INNO-LiPA genotyping extra and hybrid capture 2 assays for detection of carcinogenic human papillomavirus genotypes.
    Barzon L; Militello V; Pagni S; Palù G
    J Clin Virol; 2012 Nov; 55(3):256-61. PubMed ID: 22877561
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of HPV sign genotyping test with INNO-LiPA HPV genotyping extra assay on histologic and cytologic cervical specimens.
    Barbieri D; Nocera M; Gallinella G; Gentilomi GA; Plazzi M; Costa S; Santini D; Venturoli S
    Diagn Microbiol Infect Dis; 2012 Sep; 74(1):43-8. PubMed ID: 22717156
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High-risk HPV detection and genotyping by APTIMA HPV using cervical samples.
    Pyne MT; Hamula CL; Tardif K; Law C; Schlaberg R
    J Virol Methods; 2015 Sep; 221():95-9. PubMed ID: 25956671
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pre-vaccination prevalence of infections with 25 non-high-risk human papillomavirus types among 1,000 Slovenian women in cervical cancer screening.
    Učakar V; Poljak M; Oštrbenk A; Klavs I
    J Med Virol; 2014 Oct; 86(10):1772-9. PubMed ID: 24978445
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Detection and genotyping of HPV in urine samples from Chilean women attending primary health care centers.
    Vergara N; Balanda M; Hidalgo W; Martín HS; Aceituno A; Roldán F; Villalón T; Hott M; Espinoza G; Quiero A; Valenzuela MT; Ramírez E
    Med Microbiol Immunol; 2018 Apr; 207(2):95-103. PubMed ID: 29238853
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of SPF10 real-time PCR and conventional PCR in combination with the INNO-LiPA HPV Genotyping Extra assay for the detection and typing of human papillomavirus in cervical samples.
    Micalessi MI; Boulet GA; Pillet S; Jacquet J; Pozzetto B; Bogers JJ; Bourlet T
    J Virol Methods; 2013 Dec; 194(1-2):113-7. PubMed ID: 23978605
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevalence and genotype distribution of human papillomavirus infection of the cervix in Spain: the CLEOPATRE study.
    Castellsagué X; Iftner T; Roura E; Vidart JA; Kjaer SK; Bosch FX; Muñoz N; Palacios S; San Martin Rodriguez M; Serradell L; Torcel-Pagnon L; Cortes J;
    J Med Virol; 2012 Jun; 84(6):947-56. PubMed ID: 22499018
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prevalence of type-specific human papillomavirus infection among women in France: Implications for screening, vaccination, and a future generation of multivalent HPV vaccines.
    Monsonego J; Zerat L; Syrjänen K; Zerat JC; Smith JS; Halfon P
    Vaccine; 2012 Jul; 30(35):5215-21. PubMed ID: 22713720
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The prevalence of human papillomavirus (HPV) infection in paired urine and cervical smear samples of HIV-infected women.
    Jong E; Mulder JW; van Gorp EC; Wagenaar JK; Derksen J; Westerga J; Tol A; Smits PH
    J Clin Virol; 2008 Feb; 41(2):111-5. PubMed ID: 18354821
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Human papillomavirus quantification in urine and cervical samples by using the Mx4000 and LightCycler general real-time PCR systems.
    Payan C; Ducancelle A; Aboubaker MH; Caer J; Tapia M; Chauvin A; Peyronnet D; Le Hen E; Arab Z; Legrand MC; Tran A; Postec E; Tourmen F; Avenel M; Malbois C; De Brux MA; Descamps P; Lunel F
    J Clin Microbiol; 2007 Mar; 45(3):897-901. PubMed ID: 17229868
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The original SPF10 LiPA25 algorithm is more sensitive and suitable for epidemiologic HPV research than the SPF10 INNO-LiPA Extra.
    Geraets DT; Struijk L; Kleter B; Molijn A; van Doorn LJ; Quint WG; Colau B
    J Virol Methods; 2015 Apr; 215-216():22-9. PubMed ID: 25698462
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of the Abbott RealTime High Risk HPV test and the Roche cobas 4800 HPV test using urine samples.
    Lim MC; Lee DH; Hwang SH; Hwang NR; Lee B; Shin HY; Jun JK; Yoo CW; Lee DO; Seo SS; Park SY; Joo J
    J Virol Methods; 2017 May; 243():74-79. PubMed ID: 28161277
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Detection of 14 human papillomavirus genotypes in cervical samples in women from a central-southern area of Italy showing different Pap test results.
    Zappacosta B; Romano L; Guerriero M; Graziano M; Vitrani A; De Ninno M; Carbone A
    New Microbiol; 2009 Oct; 32(4):351-8. PubMed ID: 20128441
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.